GH1 and liver cancer: In order to evaluate the biological activity of TAT-hGH, we conducted a cell proliferation assay using two cell lines: HepG2 (a liver cancer cell, a major target organ for hGH activity) and Detroit 551 (a skin fibroblast cell line, a target cell type for topical application).